RU2018109574A - Применение хлорита для лечения болезней красных кровяных телец и опосредованных ими симптомов - Google Patents
Применение хлорита для лечения болезней красных кровяных телец и опосредованных ими симптомов Download PDFInfo
- Publication number
- RU2018109574A RU2018109574A RU2018109574A RU2018109574A RU2018109574A RU 2018109574 A RU2018109574 A RU 2018109574A RU 2018109574 A RU2018109574 A RU 2018109574A RU 2018109574 A RU2018109574 A RU 2018109574A RU 2018109574 A RU2018109574 A RU 2018109574A
- Authority
- RU
- Russia
- Prior art keywords
- patient
- pharmaceutical composition
- chlorite
- diabetes
- chlorate
- Prior art date
Links
- 229910001919 chlorite Inorganic materials 0.000 title claims 5
- 229910052619 chlorite group Inorganic materials 0.000 title claims 5
- 210000004369 blood Anatomy 0.000 title 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-M chlorite Chemical compound [O-]Cl=O QBWCMBCROVPCKQ-UHFFFAOYSA-M 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 claims 8
- 206010012601 diabetes mellitus Diseases 0.000 claims 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 4
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 claims 4
- 150000002500 ions Chemical class 0.000 claims 4
- 229910052708 sodium Inorganic materials 0.000 claims 4
- 239000011734 sodium Substances 0.000 claims 4
- 208000008960 Diabetic foot Diseases 0.000 claims 3
- 208000001647 Renal Insufficiency Diseases 0.000 claims 1
- 208000017442 Retinal disease Diseases 0.000 claims 1
- 206010038923 Retinopathy Diseases 0.000 claims 1
- 206010039020 Rhabdomyolysis Diseases 0.000 claims 1
- 208000002903 Thalassemia Diseases 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 208000007475 hemolytic anemia Diseases 0.000 claims 1
- 201000006370 kidney failure Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 208000030613 peripheral artery disease Diseases 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562207774P | 2015-08-20 | 2015-08-20 | |
| US62/207,774 | 2015-08-20 | ||
| PCT/IB2016/055011 WO2017029648A1 (en) | 2015-08-20 | 2016-08-22 | Use of chlorite to treat red blood cell diseases and indications mediated thereby |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2018109574A true RU2018109574A (ru) | 2019-09-23 |
| RU2018109574A3 RU2018109574A3 (enExample) | 2020-02-27 |
Family
ID=56896735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018109574A RU2018109574A (ru) | 2015-08-20 | 2016-08-22 | Применение хлорита для лечения болезней красных кровяных телец и опосредованных ими симптомов |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11813234B2 (enExample) |
| EP (1) | EP3337489B1 (enExample) |
| JP (2) | JP6900596B2 (enExample) |
| CN (1) | CN108135930A (enExample) |
| RU (1) | RU2018109574A (enExample) |
| WO (1) | WO2017029648A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112168841A (zh) * | 2019-07-05 | 2021-01-05 | 卢序 | 一种增加人一氧化氮生物利用度的方法 |
| CN112386606A (zh) * | 2019-08-19 | 2021-02-23 | 卢序 | 一种有第二信使作用增加积极氧化压力的氧化剂的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU754928B2 (en) | 1997-10-06 | 2002-11-28 | Oxo Chemie Ag | Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| US20040224306A1 (en) | 1999-11-30 | 2004-11-11 | Frederich-Wilhelm Kuhne | Evaluating and predicting clinical outcomes by gene expression analysis |
| EP1558237A4 (en) * | 2002-09-27 | 2007-01-17 | Martek Biosciences Corp | IMPROVED BLOOD SUGAR CONTROL F RPRU-DIABETES AND / OR DIABETES TYPE II USING DOCOSAHEXAENSURE |
| EP2081021A4 (en) * | 2006-10-16 | 2014-07-23 | Sekisui Chemical Co Ltd | HEMOGLOBIN DETERMINATION PROCESS |
| WO2008145376A1 (en) | 2007-06-01 | 2008-12-04 | Dimethaid Ag | Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis |
| US20140287064A1 (en) * | 2009-04-28 | 2014-09-25 | Karen G. Swenholt | Compositions for improving the appearance and/or treating fungal infections of nails, mucus membranes and the integument |
| EA201290041A1 (ru) | 2009-08-06 | 2012-07-30 | Ньюралтус Фармасьютикалс, Инк. | Лечение расстройств, связанных с макрофагами |
| US20110118180A1 (en) * | 2009-11-13 | 2011-05-19 | Sanofi-Aventis Deutschland Gmbh | Method of treatment of diabetes type 2 comprising add-on therapy to metformin |
| RU2014130080A (ru) | 2011-12-22 | 2016-02-10 | Нуво Рисерч Гмбх | Липосомальные композиции хлоритов или хлоратов |
| CN104519890A (zh) * | 2012-01-19 | 2015-04-15 | Ibt美国公司 | 四氯十氧(tcdo)的治疗应用 |
| US8748744B2 (en) * | 2012-06-28 | 2014-06-10 | Hubbell Incorporated | Electrical box extender assembly |
| CA2945179A1 (en) * | 2014-05-16 | 2015-11-19 | Michael S. Mcgrath | Methods and compositions for treatment of macrophage-related disorders |
-
2016
- 2016-08-22 US US15/753,516 patent/US11813234B2/en active Active
- 2016-08-22 EP EP16763581.2A patent/EP3337489B1/en active Active
- 2016-08-22 JP JP2018528106A patent/JP6900596B2/ja active Active
- 2016-08-22 CN CN201680061116.3A patent/CN108135930A/zh active Pending
- 2016-08-22 RU RU2018109574A patent/RU2018109574A/ru not_active Application Discontinuation
- 2016-08-22 WO PCT/IB2016/055011 patent/WO2017029648A1/en not_active Ceased
-
2021
- 2021-05-06 JP JP2021078253A patent/JP2021130664A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021130664A (ja) | 2021-09-09 |
| CA2995659A1 (en) | 2017-02-23 |
| JP2018523711A (ja) | 2018-08-23 |
| RU2018109574A3 (enExample) | 2020-02-27 |
| US11813234B2 (en) | 2023-11-14 |
| JP6900596B2 (ja) | 2021-07-07 |
| US20180243334A1 (en) | 2018-08-30 |
| EP3337489A1 (en) | 2018-06-27 |
| WO2017029648A1 (en) | 2017-02-23 |
| BR112018003227A2 (pt) | 2018-09-25 |
| CN108135930A (zh) | 2018-06-08 |
| EP3337489B1 (en) | 2023-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201811185YA (en) | Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viii | |
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| EA202091446A1 (ru) | Способы лечения хронических воспалительных заболеваний | |
| EA201691278A1 (ru) | Замещенные пиперидинил-тетрагидрохинолины | |
| Gepner et al. | A randomized controlled trial of the effects of vitamin D supplementation on arterial stiffness and aortic blood pressure in Native American women | |
| MY177393A (en) | Substituted piperidinyl-tetrahydroquinolines and their use as alpha-2c adrenoreceptor antagonists | |
| Zanoli et al. | Maintenance therapy with salicylates is associated with aortic stiffening in patients with inflammatory bowel disease | |
| EA201070084A1 (ru) | Новое применение известных фармакологически активных химических соединений | |
| EA202091653A1 (ru) | Миноциклин для лечения воспалительных заболеваний кожи | |
| JP2018523711A5 (enExample) | ||
| JP2019529569A5 (enExample) | ||
| Yingsakmongkol et al. | Effect of WF10 (immunokine) on diabetic foot ulcer therapy: a double-blind, randomized, placebo-controlled trial | |
| JP2023539154A5 (enExample) | ||
| Ajiboye et al. | Therapeutic effects of exercise training on selected cardio-pulmonary parameters and body composition of Nigerians with chronic heart failure (a preliminary study) | |
| BR112015009291A2 (pt) | métodos para o controle da pressão arterial e redução da dispnéia na insuficiência cardíaca | |
| MA39406B1 (fr) | Promédicament de la 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-d-proline | |
| JP2015522601A5 (enExample) | ||
| DE04291738T1 (de) | Verwendung von Citrullin zur Herstellung eines Arzneimittels zur Behandlung von intestinaler Insuffizienz | |
| CN105998054A (zh) | 脚气粉 | |
| RU2533257C1 (ru) | Инфузионный раствор "физиолит" | |
| JPWO2021235044A5 (enExample) | ||
| DE602006020838D1 (de) | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum | |
| TH1801001392A (th) | การใช้คลอไรต์สำหรับการเตรียมองค์ประกอบทางเภสัขกรรมในการบำบัดโรคของเซลล์เม็ดเลือดแดงและอาการที่มีสื่อกลางโดยสิ่งดังกล่าว | |
| Faridaalaee et al. | An interesting case of aluminum phosphide poisoning | |
| RU2006109966A (ru) | Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20210413 |